Aquestive Therapeutics EPS AQST

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Aquestive Therapeutics' earnings per share was −$0.65 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.18.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.18	n/a	−$0.65
Q1 FY26	Mar 31, 2026	−$0.07	n/a	−$0.61
Q4 FY25	Dec 31, 2025	−$0.26	n/a	−$0.78
Q3 FY25	Sep 30, 2025	−$0.14	n/a	−$0.71
Q2 FY25	Jun 30, 2025	−$0.14	n/a	−$0.70
Q1 FY25	Mar 31, 2025	−$0.24	n/a	−$0.59
Q4 FY24	Dec 31, 2024	−$0.19	n/a	−$0.52
Q3 FY24	Sep 30, 2024	−$0.13	n/a	−$0.45
Q2 FY24	Jun 30, 2024	−$0.03	n/a	−$0.35
Q1 FY24	Mar 31, 2024	−$0.17	−255%	−$0.42
Q4 FY23	Dec 31, 2023	−$0.12	n/a	−$0.14
Q3 FY23	Sep 30, 2023	−$0.03	n/a	−$0.25

Companies in Drug Manufacturers - General nearest Aquestive Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
AQSTAquestive Therapeutics	−$0.65
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
COLLCollegium Pharmaceutical	$1.24	+19% a year
ABUSArbutus Biopharma	$0.78
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
NATRNatures Sunshine Products	$1.01	+36% a year
OMEROmeros	$1.52
Peer median	$0.97